The largest ASX 200 healthcare share has dropped to a 6-year low since the company released its FY25 results. The CSL Ltd (ASX: CSL) share price reached a new six-year low of $205.82 yesterday. Today, ...
CSL was once a market darling, now it’s out of favour and pressure is on board and management to convince sceptical investors of a plan to restructure the business. CSL chairman Brian McNamee says he ...
While 2025 has been difficult for the CSL Ltd (ASX: CSL) share price to date, some analysts are optimistic that the business can deliver strong returns and mount a recovery. The market saw some ...
Hosted on MSN
BMW M4 CSL Arrival
The BMW M4 CSL making its presence known, with focus on design, performance, and style. A closer look at one of BMW’s most exciting M models for car enthusiasts and automotive fans. ‘Enough is Enough’ ...
Australia's largest biotech firm has joined a growing chorus of business leaders slamming a growing work-from-home culture amid plummeting productivity. Chairman Brian McNamee revealed there was ...
Cochin University of Science and Technology (Cusat) and Cochin Shipyard Limited (CSL) have signed a memorandum of understanding (MoU) to establish a centre of excellence in sustainable shipbuilding ...
Gift 5 articles to anyone you choose each month when you subscribe. CSL chairman Brian McNamee says Victoria’s entrenched work-from-home culture was partly responsible for research and development ...
Joy Linton, Chief Financial Officer of Australia's biotech company CSL talks about the company's restructuring, the impact of U.S. tariffs and currency volatility risks. What retirees think of Donald ...
Australia's CSL is wielding the axe, cutting its workforce by 15% – around 3,000 positions – while announcing plans to spin its vaccines unit into a standalone company. The decision to demerge the CSL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results